ID   ATS5_HUMAN              Reviewed;         930 AA.
AC   Q9UNA0; Q52LV4; Q9UKP2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   22-JUL-2015, entry version 154.
DE   RecName: Full=A disintegrin and metalloproteinase with thrombospondin motifs 5;
DE            Short=ADAM-TS 5;
DE            Short=ADAM-TS5;
DE            Short=ADAMTS-5;
DE            EC=3.4.24.-;
DE   AltName: Full=A disintegrin and metalloproteinase with thrombospondin motifs 11;
DE            Short=ADAM-TS 11;
DE            Short=ADAMTS-11;
DE   AltName: Full=ADMP-2;
DE   AltName: Full=Aggrecanase-2;
DE   Flags: Precursor;
GN   Name=ADAMTS5; Synonyms=ADAMTS11, ADMP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-138 AND PRO-692.
RC   TISSUE=Liver;
RX   PubMed=10438522; DOI=10.1074/jbc.274.33.23443;
RA   Abbaszade I., Liu R.-Q., Yang F., Rosenfeld S.A., Ross O.H.,
RA   Link J.R., Ellis D.M., Tortorella M.D., Pratta M.A., Hollis J.M.,
RA   Wynn R., Duke J.L., George H.J., Hillman M.C. Jr., Murphy K.,
RA   Wiswall B.H., Copeland R.A., Decicco C.P., Bruckner R., Nagase H.,
RA   Ito Y., Newton R.C., Magolda R.L., Trzaskos J.M., Hollis G.F.,
RA   Arner E.C., Burn T.C.;
RT   "Cloning and characterization of ADAMTS11, an aggrecanase from the
RT   ADAMTS family.";
RL   J. Biol. Chem. 274:23443-23450(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-138 AND
RP   PRO-692.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 413-930, AND VARIANTS HIS-614 AND
RP   PRO-692.
RC   TISSUE=Fetal brain;
RX   PubMed=10464288; DOI=10.1074/jbc.274.36.25555;
RA   Hurskainen T.L., Hirohata S., Seldin M.F., Apte S.S.;
RT   "ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of
RT   zinc metalloproteases.";
RL   J. Biol. Chem. 274:25555-25563(1999).
RN   [5]
RP   GLYCOSYLATION AT TRP-570; TRP-573 AND SER-582, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=19671700; DOI=10.1074/jbc.M109.038059;
RA   Wang L.W., Leonhard-Melief C., Haltiwanger R.S., Apte S.S.;
RT   "Post-translational modification of thrombospondin type-1 repeats in
RT   ADAMTS-like 1/punctin-1 by C-mannosylation of tryptophan.";
RL   J. Biol. Chem. 284:30004-30015(2009).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 262-628 IN COMPLEX WITH
RP   INHIBITOR, ACTIVE SITE, COFACTOR, ZINC-BINDING SITES, DISULFIDE BONDS,
RP   AND GLYCOSYLATION AT ASN-498.
RX   PubMed=18042673; DOI=10.1110/ps.073287008;
RA   Mosyak L., Georgiadis K., Shane T., Svenson K., Hebert T.,
RA   McDonagh T., Mackie S., Olland S., Lin L., Zhong X., Kriz R.,
RA   Reifenberg E.L., Collins-Racie L.A., Corcoran C., Freeman B.,
RA   Zollner R., Marvell T., Vera M., Sum P.E., Lavallie E.R., Stahl M.,
RA   Somers W.;
RT   "Crystal structures of the two major aggrecan degrading enzymes,
RT   ADAMTS4 and ADAMTS5.";
RL   Protein Sci. 17:16-21(2008).
CC   -!- FUNCTION: Cleaves aggrecan, a cartilage proteoglycan, and may be
CC       involved in its turnover. May play an important role in the
CC       destruction of aggrecan in arthritic diseases. May play a role in
CC       proteolytic processing mostly during the peri-implantation period.
CC   -!- CATALYTIC ACTIVITY: Cleaves aggrecan at the 392-Glu-|-Ala-393
CC       site.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:18042673};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:18042673};
CC   -!- INTERACTION:
CC       P13608:ACAN (xeno); NbExp=2; IntAct=EBI-2808663, EBI-6259246;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed at low level in placenta primarily
CC       but also detected in heart and brain, cervix, uterus, bladder,
CC       esophagus, rib cartilage, chondroblastoma, fibrous tissue and a
CC       joint capsule from an arthritic patient.
CC   -!- DOMAIN: The spacer domain and the TSP type-1 domains are important
CC       for a tight interaction with the extracellular matrix.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch
CC       motif binds the catalytic zinc ion, thus inhibiting the enzyme.
CC       The dissociation of the cysteine from the zinc ion upon the
CC       activation-peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250}.
CC   -!- PTM: C- and O-glycosylated. O-fucosylated by POFUT2 on a serine or
CC       a threonine residue found within the consensus sequence C1-X(2)-
CC       (S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are
CC       the first and second cysteine residue of the repeat, respectively.
CC       Fucosylated repeats can then be further glycosylated by the
CC       addition of a beta-1,3-glucose residue by the glucosyltransferase,
CC       B3GALTL. Fucosylation can mediate the efficient secretion of
CC       ADAMTS family members. Can be C-glycosylated with one or two
CC       mannose molecules on tryptophan residues within the consensus
CC       sequence W-X-X-W of the TPRs, and N-glycosylated. These other
CC       glycosylations can also facilitate secretion (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a
CC       threonine residue found within the consensus sequence C1-X(2)-
CC       (S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are
CC       the first and second cysteine residue of the repeat, respectively.
CC       Fucosylated repeats can then be further glycosylated by the
CC       addition of a beta-1,3-glucose residue by the glucosyltransferase,
CC       B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS
CC       family members. Also can be C-glycosylated with one or two mannose
CC       molecules on tryptophan residues within the consensus sequence W-
CC       X-X-W of the TPRs, and N-glycosylated. These other glycosylations
CC       can also facilitate secretion (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Contains 1 disintegrin domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 peptidase M12B domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00276}.
CC   -!- SIMILARITY: Contains 2 TSP type-1 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00210}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF142099; AAD49577.1; -; mRNA.
DR   EMBL; AP001698; BAA95504.1; -; Genomic_DNA.
DR   EMBL; AP001697; BAA95503.1; -; Genomic_DNA.
DR   EMBL; BC093775; AAH93775.1; -; mRNA.
DR   EMBL; BC093777; AAH93777.1; -; mRNA.
DR   EMBL; AF141293; AAF02493.1; -; mRNA.
DR   CCDS; CCDS13579.1; -.
DR   RefSeq; NP_008969.2; NM_007038.3.
DR   UniGene; Hs.58324; -.
DR   PDB; 2RJQ; X-ray; 2.60 A; A=262-628.
DR   PDB; 3B8Z; X-ray; 1.40 A; A/B=264-480.
DR   PDB; 3HY7; X-ray; 1.69 A; A/B=262-480.
DR   PDB; 3HY9; X-ray; 2.02 A; A/B=262-480.
DR   PDB; 3HYG; X-ray; 1.40 A; A/B=262-480.
DR   PDB; 3LJT; X-ray; 1.60 A; A=264-480.
DR   PDBsum; 2RJQ; -.
DR   PDBsum; 3B8Z; -.
DR   PDBsum; 3HY7; -.
DR   PDBsum; 3HY9; -.
DR   PDBsum; 3HYG; -.
DR   PDBsum; 3LJT; -.
DR   ProteinModelPortal; Q9UNA0; -.
DR   SMR; Q9UNA0; 259-797, 880-926.
DR   IntAct; Q9UNA0; 3.
DR   STRING; 9606.ENSP00000284987; -.
DR   BindingDB; Q9UNA0; -.
DR   ChEMBL; CHEMBL2285; -.
DR   MEROPS; M12.225; -.
DR   PhosphoSite; Q9UNA0; -.
DR   BioMuta; ADAMTS5; -.
DR   DMDM; 317373326; -.
DR   PaxDb; Q9UNA0; -.
DR   PRIDE; Q9UNA0; -.
DR   Ensembl; ENST00000284987; ENSP00000284987; ENSG00000154736.
DR   GeneID; 11096; -.
DR   KEGG; hsa:11096; -.
DR   UCSC; uc002ymg.3; human.
DR   CTD; 11096; -.
DR   GeneCards; GC21M028290; -.
DR   H-InvDB; HIX0016044; -.
DR   HGNC; HGNC:221; ADAMTS5.
DR   HPA; CAB025996; -.
DR   HPA; HPA005661; -.
DR   MIM; 605007; gene.
DR   neXtProt; NX_Q9UNA0; -.
DR   eggNOG; NOG302522; -.
DR   GeneTree; ENSGT00760000118880; -.
DR   HOGENOM; HOG000004799; -.
DR   HOVERGEN; HBG004313; -.
DR   InParanoid; Q9UNA0; -.
DR   KO; K08620; -.
DR   OMA; RASCETP; -.
DR   OrthoDB; EOG7WDN1M; -.
DR   PhylomeDB; Q9UNA0; -.
DR   TreeFam; TF331949; -.
DR   BRENDA; 3.4.24.B12; 2681.
DR   Reactome; REACT_118572; Degradation of the extracellular matrix.
DR   Reactome; REACT_264269; O-glycosylation of TSR domain-containing proteins.
DR   ChiTaRS; ADAMTS5; human.
DR   EvolutionaryTrace; Q9UNA0; -.
DR   GeneWiki; ADAMTS5; -.
DR   GenomeRNAi; 11096; -.
DR   NextBio; 42182; -.
DR   PMAP-CutDB; Q9UNA0; -.
DR   PRO; PR:Q9UNA0; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; Q9UNA0; -.
DR   CleanEx; HS_ADAMTS5; -.
DR   Genevisible; Q9UNA0; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005178; F:integrin binding; TAS:ProtInc.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR   GO; GO:0008237; F:metallopeptidase activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:Ensembl.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0036066; P:protein O-linked fucosylation; TAS:Reactome.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR010294; ADAM_spacer1.
DR   InterPro; IPR024079; MetalloPept_cat_dom.
DR   InterPro; IPR013276; Pept_M12B_ADAM-TS5.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR013273; Peptidase_M12B_ADAM-TS.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   InterPro; IPR000884; Thrombospondin_1_rpt.
DR   Pfam; PF05986; ADAM_spacer1; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   Pfam; PF01421; Reprolysin; 1.
DR   Pfam; PF00090; TSP_1; 2.
DR   PRINTS; PR01860; ADAMTS5.
DR   PRINTS; PR01857; ADAMTSFAMILY.
DR   SMART; SM00209; TSP1; 2.
DR   SUPFAM; SSF82895; SSF82895; 2.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50092; TSP1; 2.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cleavage on pair of basic residues; Complete proteome;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Hydrolase;
KW   Metal-binding; Metalloprotease; Polymorphism; Protease;
KW   Reference proteome; Repeat; Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   PROPEP       17    261       {ECO:0000255}.
FT                                /FTId=PRO_0000029170.
FT   CHAIN       262    930       A disintegrin and metalloproteinase with
FT                                thrombospondin motifs 5.
FT                                /FTId=PRO_0000029171.
FT   DOMAIN      267    476       Peptidase M12B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00276}.
FT   DOMAIN      485    566       Disintegrin.
FT   DOMAIN      567    622       TSP type-1 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      875    929       TSP type-1 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   REGION      732    874       Spacer.
FT   MOTIF       207    214       Cysteine switch. {ECO:0000250}.
FT   COMPBIAS     37     41       Poly-Ala.
FT   COMPBIAS    257    261       Poly-Arg.
FT   COMPBIAS    624    731       Cys-rich.
FT   ACT_SITE    411    411       {ECO:0000255|PROSITE-ProRule:PRU00276,
FT                                ECO:0000255|PROSITE-ProRule:PRU10095,
FT                                ECO:0000269|PubMed:18042673}.
FT   METAL       209    209       Zinc; in inhibited form. {ECO:0000250}.
FT   METAL       410    410       Zinc; catalytic.
FT   METAL       414    414       Zinc; catalytic.
FT   METAL       420    420       Zinc; catalytic.
FT   CARBOHYD    498    498       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:18042673}.
FT   CARBOHYD    570    570       C-linked (Man).
FT   CARBOHYD    573    573       C-linked (Man).
FT   CARBOHYD    582    582       O-linked (Fuc...).
FT                                {ECO:0000269|PubMed:19671700}.
FT   CARBOHYD    728    728       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    802    802       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    807    807       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    342    394       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    371    376       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    388    471       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    426    455       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    497    519       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    508    529       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    514    548       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    542    553       {ECO:0000269|PubMed:18042673}.
FT   DISULFID    579    616       {ECO:0000250}.
FT   DISULFID    583    621       {ECO:0000250}.
FT   DISULFID    594    606       {ECO:0000250}.
FT   VARIANT     138    138       G -> A (in dbSNP:rs457947).
FT                                {ECO:0000269|PubMed:10438522,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028199.
FT   VARIANT     614    614       R -> H (in dbSNP:rs2830585).
FT                                {ECO:0000269|PubMed:10464288}.
FT                                /FTId=VAR_021849.
FT   VARIANT     692    692       L -> P (in dbSNP:rs226794).
FT                                {ECO:0000269|PubMed:10438522,
FT                                ECO:0000269|PubMed:10464288,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028200.
FT   STRAND      267    275       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       277    283       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       284    286       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       287    302       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       305    307       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      311    320       {ECO:0000244|PDB:3B8Z}.
FT   TURN        323    326       {ECO:0000244|PDB:3HYG}.
FT   HELIX       334    348       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      353    356       {ECO:0000244|PDB:3LJT}.
FT   STRAND      360    368       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      380    382       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       390    392       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      394    398       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      401    403       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       404    415       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       424    430       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      435    437       {ECO:0000244|PDB:3B8Z}.
FT   STRAND      440    442       {ECO:0000244|PDB:2RJQ}.
FT   HELIX       443    445       {ECO:0000244|PDB:3LJT}.
FT   HELIX       454    465       {ECO:0000244|PDB:3B8Z}.
FT   TURN        466    469       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       470    472       {ECO:0000244|PDB:3B8Z}.
FT   HELIX       487    490       {ECO:0000244|PDB:2RJQ}.
FT   HELIX       493    501       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      509    511       {ECO:0000244|PDB:2RJQ}.
FT   TURN        513    515       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      519    523       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      526    530       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      543    545       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      547    549       {ECO:0000244|PDB:2RJQ}.
FT   STRAND      552    554       {ECO:0000244|PDB:2RJQ}.
SQ   SEQUENCE   930 AA;  101718 MW;  8CCE448A15A29CE8 CRC64;
     MLLGWASLLL CAFRLPLAAV GPAATPAQDK AGQPPTAAAA AQPRRRQGEE VQERAEPPGH
     PHPLAQRRRS KGLVQNIDQL YSGGGKVGYL VYAGGRRFLL DLERDGSVGI AGFVPAGGGT
     SAPWRHRSHC FYRGTVDGSP RSLAVFDLCG GLDGFFAVKH ARYTLKPLLR GPWAEEEKGR
     VYGDGSARIL HVYTREGFSF EALPPRASCE TPASTPEAHE HAPAHSNPSG RAALASQLLD
     QSALSPAGGS GPQTWWRRRR RSISRARQVE LLLVADASMA RLYGRGLQHY LLTLASIANR
     LYSHASIENH IRLAVVKVVV LGDKDKSLEV SKNAATTLKN FCKWQHQHNQ LGDDHEEHYD
     AAILFTREDL CGHHSCDTLG MADVGTICSP ERSCAVIEDD GLHAAFTVAH EIGHLLGLSH
     DDSKFCEETF GSTEDKRLMS SILTSIDASK PWSKCTSATI TEFLDDGHGN CLLDLPRKQI
     LGPEELPGQT YDATQQCNLT FGPEYSVCPG MDVCARLWCA VVRQGQMVCL TKKLPAVEGT
     PCGKGRICLQ GKCVDKTKKK YYSTSSHGNW GSWGSWGQCS RSCGGGVQFA YRHCNNPAPR
     NNGRYCTGKR AIYRSCSLMP CPPNGKSFRH EQCEAKNGYQ SDAKGVKTFV EWVPKYAGVL
     PADVCKLTCR AKGTGYYVVF SPKVTDGTEC RLYSNSVCVR GKCVRTGCDG IIGSKLQYDK
     CGVCGGDNSS CTKIVGTFNK KSKGYTDVVR IPEGATHIKV RQFKAKDQTR FTAYLALKKK
     NGEYLINGKY MISTSETIID INGTVMNYSG WSHRDDFLHG MGYSATKEIL IVQILATDPT
     KPLDVRYSFF VPKKSTPKVN SVTSHGSNKV GSHTSQPQWV TGPWLACSRT CDTGWHTRTV
     QCQDGNRKLA KGCPLSQRPS AFKQCLLKKC
//
